drugset / Trial / NCT01206335
Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether patients with advanced cancers who receive OHR/AVR118 solution for injection into the skin can achieve improvement in quality of life. Based on a previous study in patients with AIDS, possible benefits may include improved appetite and strength; weight gain, improved mood; and decreased fatigue.
Timeline
- Start
- 2010-09
- Primary completion
- 2012-12
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OHR/AVR118 | Unknown | 4 ml | Subcutaneous |